Intuitive Surgical Is Down 28%, and Wall Street Is Piling On. Goldman Sachs Just Said Everyone Is Wrong -- and History Is on Its Side.
Intuitive Surgical has faced margin pressure before and bounced back.
Overview
A 28% drop in Intuitive Surgical (NASDAQ: ISRG) stock this year has left investors anxious, but an analyst from Goldman Sachs argues the panic regarding the medical device maker is rooted in a misunderstanding of two major changes to Intuitive's instrument lifetimes.
Several analysts downgraded their positions in Intuitive after its first-quarter earnings, including those with Deutsche Bank, Bank of America, JPMorgan Chase, and HSBC. David Roman of Goldman Sachs, on the other hand, upped the stock's price target to $558.
Details
Here is what changed, why the market reacted defensively, and what matters next.
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.